Blood Loss During Cesarean Delivery in Placenta Previa Patients
Status:
Not yet recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety profile of intravenous tranexamic acid versus intrauterine
misoprostol in reducing the blood loss during and after cesarean delivery in pregnant women
diagnosed with placenta previa